Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia.

Inamoto Y, Lee SJ, Onstad LE, Flowers MED, Hamilton BK, Jagasia MH, Martin PJ, Pavletic SZ, Pidala JA, Pusic I, Vogelsang GB, Wolff D, Carpenter PA.

Blood Adv. 2020 Jan 14;4(1):40-46. doi: 10.1182/bloodadvances.2019000918.

2.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.

Martin PJ, Lee SJ, Przepiorka D, Horowitz MM, Koreth J, Vogelsang GB, Walker I, Carpenter PA, Griffith LM, Akpek G, Mohty M, Wolff D, Pavletic SZ, Cutler CS.

Biol Blood Marrow Transplant. 2015 Aug;21(8):1343-59. doi: 10.1016/j.bbmt.2015.05.004. Epub 2015 May 15. Review.

3.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Carpenter PA, Kitko CL, Elad S, Flowers ME, Gea-Banacloche JC, Halter JP, Hoodin F, Johnston L, Lawitschka A, McDonald GB, Opipari AW, Savani BN, Schultz KR, Smith SR, Syrjala KL, Treister N, Vogelsang GB, Williams KM, Pavletic SZ, Martin PJ, Lee SJ, Couriel DR.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1167-87. doi: 10.1016/j.bbmt.2015.03.024. Epub 2015 Mar 31.

4.

NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers ME, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE.

Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603. doi: 10.1016/j.bbmt.2014.12.031. Epub 2015 Jan 29.

5.

2014 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: preface to the series.

Pavletic SZ, Vogelsang GB, Lee SJ.

Biol Blood Marrow Transplant. 2015 Mar;21(3):387-8. doi: 10.1016/j.bbmt.2014.12.035. Epub 2015 Jan 5. No abstract available.

6.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME.

Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18.

7.

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.

Inamoto Y, Martin PJ, Storer BE, Palmer J, Weisdorf DJ, Pidala J, Flowers ME, Arora M, Jagasia M, Arai S, Chai X, Pavletic SZ, Vogelsang GB, Lee SJ; Chronic GVHD Consortium.

Haematologica. 2014 Oct;99(10):1618-23. doi: 10.3324/haematol.2014.109611. Epub 2014 Jul 4.

8.

Assessment of joint and fascia manifestations in chronic graft-versus-host disease.

Inamoto Y, Pidala J, Chai X, Kurland BF, Weisdorf D, Flowers ME, Palmer J, Arai S, Jacobsohn D, Cutler C, Jagasia M, Goldberg JD, Martin PJ, Pavletic SZ, Vogelsang GB, Lee SJ, Carpenter PA; Chronic GVHD Consortium.

Arthritis Rheumatol. 2014 Apr;66(4):1044-52. doi: 10.1002/art.38293.

9.

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

Palmer J, Williams K, Inamoto Y, Chai X, Martin PJ, Tomas LS, Cutler C, Weisdorf D, Kurland BF, Carpenter PA, Pidala J, Pavletic SZ, Wood W, Jacobsohn D, Arai S, Arora M, Jagasia M, Vogelsang GB, Lee SJ.

Biol Blood Marrow Transplant. 2014 Mar;20(3):337-44. doi: 10.1016/j.bbmt.2013.11.025. Epub 2013 Dec 4.

10.

Order out of chaos.

Vogelsang GB.

Blood. 2013 Mar 21;121(12):2170-2. doi: 10.1182/blood-2013-01-480491. No abstract available.

PMID:
23520329
11.

Clinical benefit of response in chronic graft-versus-host disease.

Inamoto Y, Martin PJ, Chai X, Jagasia M, Palmer J, Pidala J, Cutler C, Pavletic SZ, Arora M, Jacobsohn D, Carpenter PA, Flowers ME, Khera N, Vogelsang GB, Weisdorf D, Storer BE, Lee SJ; Chronic GVHD Consortium.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1517-24. doi: 10.1016/j.bbmt.2012.05.016. Epub 2012 Jun 6.

12.

The Serenity Prayer for acute GVHD.

Vogelsang GB.

Blood. 2012 Jan 5;119(1):3-4. doi: 10.1182/blood-2011-11-388215. No abstract available.

PMID:
22223818
13.

Validation of measurement scales in ocular graft-versus-host disease.

Inamoto Y, Chai X, Kurland BF, Cutler C, Flowers ME, Palmer JM, Carpenter PA, Heffernan MJ, Jacobsohn D, Jagasia MH, Pidala J, Khera N, Vogelsang GB, Weisdorf D, Martin PJ, Pavletic SZ, Lee SJ; Chronic GVHD Consortium.

Ophthalmology. 2012 Mar;119(3):487-93. doi: 10.1016/j.ophtha.2011.08.040. Epub 2011 Dec 6.

14.

Cracking the cement overcoat.

Vogelsang GB.

Blood. 2011 Oct 13;118(15):4010-2. doi: 10.1182/blood-2011-08-372300. No abstract available.

PMID:
21998332
15.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

Arai S, Jagasia M, Storer B, Chai X, Pidala J, Cutler C, Arora M, Weisdorf DJ, Flowers ME, Martin PJ, Palmer J, Jacobsohn D, Pavletic SZ, Vogelsang GB, Lee SJ.

Blood. 2011 Oct 13;118(15):4242-9. doi: 10.1182/blood-2011-03-344390. Epub 2011 Jul 26.

16.

A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.

Mitchell SA, Jacobsohn D, Thormann Powers KE, Carpenter PA, Flowers ME, Cowen EW, Schubert M, Turner ML, Lee SJ, Martin P, Bishop MR, Baird K, Bolaños-Meade J, Boyd K, Fall-Dickson JM, Gerber LH, Guadagnini JP, Imanguli M, Krumlauf MC, Lawley L, Li L, Reeve BB, Clayton JA, Vogelsang GB, Pavletic SZ.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1619-29. doi: 10.1016/j.bbmt.2011.04.002. Epub 2011 Apr 12.

17.

Slashing the picture of Dorian Gray.

Vogelsang GB.

Blood. 2011 Mar 17;117(11):2990. doi: 10.1182/blood-2011-02-334581. No abstract available.

PMID:
21415276
18.

Rapid engraftment at a cost?

Goldberg JD, Vogelsang GB.

Transplantation. 2010 Nov 15;90(9):949-50. doi: 10.1097/TP.0b013e3181f585ee. No abstract available.

PMID:
20802399
19.

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, Ayuk F, Kiani A, Schwerdtfeger R, Vogelsang GB, Kobbe G, Gramatzki M, Lawitschka A, Mohty M, Pavletic SZ, Greinix H, Holler E.

Biol Blood Marrow Transplant. 2011 Jan;17(1):1-17. doi: 10.1016/j.bbmt.2010.05.011. Epub 2010 May 26.

20.

Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.

Wolff D, Gerbitz A, Ayuk F, Kiani A, Hildebrandt GC, Vogelsang GB, Elad S, Lawitschka A, Socie G, Pavletic SZ, Holler E, Greinix H.

Biol Blood Marrow Transplant. 2010 Dec;16(12):1611-28. doi: 10.1016/j.bbmt.2010.06.015. Epub 2010 Jun 25.

21.

Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.

Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, McDonald GB, Guinan EC.

Biol Blood Marrow Transplant. 2010 Jul;16(7):1005-17. doi: 10.1016/j.bbmt.2010.02.009. Epub 2010 Feb 16.

22.

Keeping up with Blood: introducing our CME program.

Vogelsang GB, Dunbar CE.

Blood. 2010 Jan 28;115(4):756. doi: 10.1182/blood-2010-01-263004. No abstract available.

PMID:
20110432
23.

Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.

Jacobsohn DA, Gilman AL, Rademaker A, Browning B, Grimley M, Lehmann L, Nemecek ER, Thormann K, Schultz KR, Vogelsang GB.

Blood. 2009 Nov 12;114(20):4354-60. doi: 10.1182/blood-2009-05-224840. Epub 2009 Sep 10.

PMID:
19745067
24.

Magic bullet, part III?

Vogelsang GB.

Blood. 2009 Jul 16;114(3):498-9. doi: 10.1182/blood-2009-05-220707.

PMID:
19608756
25.

Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD.

Jacobsohn DA, Rademaker A, Kaup M, Vogelsang GB.

Bone Marrow Transplant. 2009 Dec;44(12):813-9. doi: 10.1038/bmt.2009.84. Epub 2009 May 11.

PMID:
19430498
26.

Chronic graft-versus-host disease.

Bolaños-Meade J, Vogelsang GB.

Curr Pharm Des. 2008;14(20):1974-86. Review.

PMID:
18691108
27.

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Griffith LM, Pavletic SZ, Lee SJ, Martin PJ, Schultz KR, Vogelsang GB.

Biol Blood Marrow Transplant. 2008 Apr;14(4):379-84. doi: 10.1016/j.bbmt.2008.01.005. No abstract available.

28.

Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.

Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R, Kasamon YL, Swinnen LJ, Flinn IW, Ambinder RF, Jones RJ, Hess AD, Vogelsang GB.

Biol Blood Marrow Transplant. 2007 Oct;13(10):1185-91. Epub 2007 Aug 3.

29.

Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.

Jacobsohn DA, Chen AR, Zahurak M, Piantadosi S, Anders V, Bolaños-Meade J, Higman M, Margolis J, Kaup M, Vogelsang GB.

J Clin Oncol. 2007 Sep 20;25(27):4255-61.

PMID:
17878478
30.

Acute graft versus host disease.

Jacobsohn DA, Vogelsang GB.

Orphanet J Rare Dis. 2007 Sep 4;2:35. Review.

32.

Grover's Disease after Bone Marrow Transplantation.

Bolaños-Meade J, Anders V, Wisell J, Farmer ER, Vogelsang GB.

Biol Blood Marrow Transplant. 2007 Sep;13(9):1116-7. No abstract available.

33.
34.

Montelukast in chronic graft-versus-host disease: a breath of fresh air?

Bolaños-Meade J, Vogelsang GB.

Transplantation. 2007 Mar 15;83(5):527-8. No abstract available.

PMID:
17353767
35.

Mesenchymal stem cells and organ transplantation: current status and promising future.

Bolaños-Meade J, Vogelsang GB.

Transplantation. 2006 May 27;81(10):1388-9. No abstract available.

PMID:
16732174
36.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report.

Martin PJ, Weisdorf D, Przepiorka D, Hirschfeld S, Farrell A, Rizzo JD, Foley R, Socie G, Carter S, Couriel D, Schultz KR, Flowers ME, Filipovich AH, Saliba R, Vogelsang GB, Pavletic SZ, Lee SJ; Design of Clinical Trials Working Group.

Biol Blood Marrow Transplant. 2006 May;12(5):491-505.

37.

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.

Huff CA, Fuchs EJ, Smith BD, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH, Vogelsang GB, Griffin CA, Luznik L, Jones RJ.

Biol Blood Marrow Transplant. 2006 Apr;12(4):414-21.

38.

Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report.

Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers ME.

Biol Blood Marrow Transplant. 2006 Apr;12(4):375-96.

39.

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

Pavletic SZ, Martin P, Lee SJ, Mitchell S, Jacobsohn D, Cowen EW, Turner ML, Akpek G, Gilman A, McDonald G, Schubert M, Berger A, Bross P, Chien JW, Couriel D, Dunn JP, Fall-Dickson J, Farrell A, Flowers ME, Greinix H, Hirschfeld S, Gerber L, Kim S, Knobler R, Lachenbruch PA, Miller FW, Mittleman B, Papadopoulos E, Parsons SK, Przepiorka D, Robinson M, Ward M, Reeve B, Rider LG, Shulman H, Schultz KR, Weisdorf D, Vogelsang GB; Response Criteria Working Group.

Biol Blood Marrow Transplant. 2006 Mar;12(3):252-66.

40.

Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.

Schultz KR, Miklos DB, Fowler D, Cooke K, Shizuru J, Zorn E, Holler E, Ferrara J, Shulman H, Lee SJ, Martin P, Filipovich AH, Flowers ME, Weisdorf D, Couriel D, Lachenbruch PA, Mittleman B, Vogelsang GB, Pavletic SZ.

Biol Blood Marrow Transplant. 2006 Feb;12(2):126-37.

41.

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers ME, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, Vogelsang GB.

Biol Blood Marrow Transplant. 2006 Jan;12(1):31-47.

42.

Acute graft-versus-host disease.

Bolaños-Meade J, Vogelsang GB.

Clin Adv Hematol Oncol. 2004 Oct;2(10):672-82. Review.

PMID:
16163254
43.

Toxic absorption of tacrolimus [corrected] in a patient with severe acute graft-versus-host disease.

Neuman DL, Farrar JE, Moresi JM, Vogelsang GB, Higman MA.

Bone Marrow Transplant. 2005 Nov;36(10):919-20. No abstract available. Erratum in: Bone Marrow Transplant. 2006 Jul;38(1):81.

PMID:
16151424
44.

The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.

Wu JM, Bensen-Kennedy D, Miura Y, Thoburn CJ, Armstrong D, Vogelsang GB, Hess AD.

Biol Blood Marrow Transplant. 2005 Jun;11(6):455-64.

45.

Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.

Bolaños-Meade J, Ioffe O, Hey JC, Vogelsang GB, Akpek G.

Am J Hematol. 2005 Jun;79(2):132-5.

46.

Pentostatin in steroid-refractory acute graft-versus-host disease.

Bolaños-Meade J, Jacobsohn DA, Margolis J, Ogden A, Wientjes MG, Byrd JC, Lucas DM, Anders V, Phelps M, Grever MR, Vogelsang GB.

J Clin Oncol. 2005 Apr 20;23(12):2661-8.

PMID:
15837980
47.

A case of retroperitoneal fibrosis in a patient following HSCT.

Nanda A, Rizzo JD, Vogelsang GB.

Bone Marrow Transplant. 2005 Jun;35(11):1125-6. No abstract available.

PMID:
15821767
48.

Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.

Goldberg J, Jacobsohn DA, Zahurak ML, Vogelsang GB.

Biol Blood Marrow Transplant. 2005 Feb;11(2):101-7.

49.

Novel strategies for steroid-refractory acute graft-versus-host disease.

Bolaños-Meade J, Vogelsang GB.

Curr Opin Hematol. 2005 Jan;12(1):40-4. Review.

PMID:
15604890
50.

Pentostatin - pharmacology, immunology, and clinical effects in graft-versus-host disease.

Higman M, Vogelsang GB, Chen A.

Expert Opin Pharmacother. 2004 Dec;5(12):2605-13. Review.

PMID:
15571477

Supplemental Content

Loading ...
Support Center